University of Crete (UOC)
Μελέτη του ρόλου των πρωτεογλυκανών θειικής ηπαράνης σε κυτταρικές σειρές ανθρώπινου μελανώματος μεταστατικής και πρωτοπαθούς προέλευσης: έλεγχος και συγκριτική ανάλυση της βιοσύνθεσης, της βιοδιαθεσιμότητας και της συνεισφοράς αυτών των πρωτεογλυκανών στον καρκινικό φαινότυπο
Abstract
dc:descriptionMelanoma is an aggressive cancer, deriving from malignant transformation ofmelanocytes. Melanocytes are attached on to the basal membrane-containingkeratinocytes and produce melanin. Extracellular matrix and melanoma cellinteractions are important regulators of melanoma progression and their study becomes essential because of the increased frequency and poor prognosis at the early stages of melanoma stages.Proteoglycans (PGs) are complex macromolecules consisting of glycosaminoglycans (GAGs) - covalently attached on to the protein core. They are divided into different isoforms according to their location, in extracellular, cell membrane and intracellular PGs. Heparan sulplhate proteoglycans (HSPGs) act as coreceptors on the cell surface. These receptors may affect many cellular events, including cell proliferation, cell adhesion and differentiation, by inducing intracellularsignals. Melanoma cells interact with their surrounding environment through cell -cellcontact, producing numerous molecules. Autocrine growth factors such as FGF-2produced by melanoma cells stimulate cell proliferation, whereas paracrine growthfactors such as PDGF and VEGF, regulate tumour cell growth and cell invasion byinducing changes in the environment. Growth factors expressed by melanoma cellsincluding PDGF, FGF-2, VEGF, and TGFb, stimulate radial (RGP) or vertical growthphase (VGP) formation, indicating a key role in cancer progression. FGF-2, TGF band PDGF are overexpressed either in VGP or in metastatic melanoma cells. Fibroblast growth factor-2 (FGF-2), the most abundant growth factor producedby melanoma cells but not by normal melanocytes, is an important regulator of cellproliferation, migration and differentiation. In this study we show that M5 humanmetastatic melanoma cells’ ability to migrate is significantly enhanced byexogenously added FGF-2 while, neutralization of endogenous FGF-2 stimulates their adhesion. Previously, we have demonstrated that FGF-2 distinctly modulates the synthesis of individual (GAGs/PGs) subclasses, changing both their amounts anddistribution in M5 cells. Here, treatment with FGF-2 strongly reduces the expression levels of the heparan sulphate containing proteoglycan, syndecan-4. Syndecan-4 is a focal adhesion component in a range of cell types, adherent to several different matrix molecules, including fibronectin (FN). The reduction in syndecan- 4 expression byutilizing specific siRNA discriminately increased melanoma cell motility and decreased their attachment on FN, demonstrating a regulatory role of syndecan-4 onthese cell functions. Syndecan-4 has previously been demonstrated to regulate focal adhesion kinase (FAK) phosphorylation. In this study FGF-2 was shown to downregulate FAK Y397-phosphorylation during FN-mediated M5 cell adhesion, promoting their migration. The observed decrease in FAK Y397 activation was correlated to syndecan-4 expression levels. Thus, a balance in syndecan-4 expression perpetrated by FGF-2 may be required for optimal M5 cell migration. Heparin and its various derivatives affect cancer progression in humans. In this study, we show that heparin uptaken intracellularly by melanoma cells activated a signaling cascade, which in turn inhibited melanoma cell adhesion and migration. The reduced ability of M5 cells to adhere onto the FN substrate was directly correlated to a decrease in the expression of focal adhesion kinase (FAK), which is a key regulator of melanoma motility. Cell treatment with heparin caused a marked downregulation inFAK expression (P <0.01). This is followed by an analogous inhibition of bothconstitutive and FN-induced FAK Y397-phosphorylation (P< 0.01). Moreover, heparin stimulated the P53 expression (P <0.001) of M5 cells and its increased accumulation in the nucleus. This favours a decrease in FAK promoter activation and explains the reduced FAK transcript and protein levels. In conclusion, the results ofthis study clearly demonstrate that the action of heparin in the regulation of melanoma cell adhesion and migration involves a P53/FAK/signaling pathway. Low molecular weight heparin (LMWH) has significant antimetastatic capabilities and affects cancer progression in humans. However, the mechanism by which LMWH affects cancer cell behavior is not known. Here we evaluated its activity at the intracellular level and how it is correlated with melanoma cell adhesionand migration. Treatment of M5 melanoma cells with LMWH caused a marked downregulation of constitutive phosphorylation as well as the FN-induced phosphorylation(p≤0,01) in protein kinase alpha (PKCa), as demonstrated by confocal microscopyand western blotting, LMWH treatment altered the distribution of pPKCa between the cytoplasm and nuclear region with a profound decrease in the cytoplasmic pPKCa (p≤0,05) and a simultaneous enhancement of nuclear pPKCa localization (p≤ 0,01). A significant decrease in the levels of pJNK (p≤0,01), which is a downstream effector ofPKCa, was also demonstrated in the LMWH-treated cells. The lineage activation ofPKCa-JNK / p38 and their correlation to M5 cell adhesion was confirmed with the utilization of specific inhibitors. The reduced ability of the LMWH-treated M5 melanoma cells to adhere onto the fibronectin (FN) substrate (p≤0,01) was directly correlated to a decrease in the activation of PKCa which is an important regulator of cell motility. LMWH-treated cells had disorganized actin stress fibers with a diffuse distribution of non-polymerized actin correlated to a strong decrease in cell –substratum interface area (p≤0,05) and altered morphology. It is postulated that LMWH through the downregulation of pPKCa and redistribution to nuclear regionattenuates JNK activation, which in turn induces cytoskeleton changes correlated toM5 cell decreased adhesion / migration. Conclusively, we show that the action of LMWH in the regulation of melanoma cell adhesion and migration involves a PKCa/JNK/ actin signalling pathway, which may be of paramount importance in the pharmacological targeting of melanoma. In conclusion we described important information regarding the mechanismsinvolved in the regulation of HSPGs and their biological behavior in human melanoma cells. Melanoma is one of the most aggressive skin cancers, and there is no prognosis available in the early stages of cancer. Thus continuous studies of the mechanisms involved in the development of melanoma, may offer candidate molecules and markers to aid melanoma prognosis and treatment.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Χαλκιαδάκη, Γεωργία
- Chalkiadaki, Georgia
Subjects
dc:subject × 18- Πρωτεογλυκάνες
- Ηπαρίνη
- Γλυκοζαμινογλυκάνη
- Θειική ηπαράνη
- Ινονεκτίνη
- Μελανώματα
- Εξωκυττάρια θεμέλια ουσία
- Proteoglycans
- Heparin
- Glycosaminoglycans
- Heparan sulfate
- Fibronectin
- Melanoma
- Extracellular matrix
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25891